Health Condition 1: B20- Human immunodeficiency virus [HIV]disease Health Condition 2: N738- Other specified female pelvic inflammatory diseases
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Sexually active women in the age group =18 years visiting the Integrated Counselling and Testing Centre (ICTC) for HIV testing.
Exclusion criteria
Exclusion criteria: 1.Women with history of any ongoing active infections e.g. TB or any other immunomodulatory disease. 2.Women currently on ART therapy, steroid treatment and pre-operative cases. 3.Women who are pregnant. 4.Women undergoing cryotherapy, Loop Electrosurgical Excision Procedure(LEEP), Chemo or radiotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Comparison of Systemic and Cervical immune expression 2.Influence of the specific HPV genotype and genetic signature on the immune markers during a coinfection. 3.Immunophenotype and cytokine profile of patients infect with HIV, HPV & having a HIV-HPV coinfection 4.Comparison of Systemic and Cervical immune expression Timepoint: As this is an observational study there are no defined time lines. | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Jayanthi Shastri
COE in Research and Training in Infectious Diseases
Outcome results
None listed